Beauty Farm Medical and Health Industry stock has crept higher in recent weeks, yet the real drama is in the earnings tape. The company just reported another period of strong profit generation, with trailing twelve month earnings from continuing operations of ¥408.874m and a trailing net profit margin of 11.2%. That is a solid level for a high touch consumer services business, and it helps explain why the shares trade on a P/E of 10.8x.

The question now is whether that earnings strength still justifies a premium price tag once investors work through the full set of numbers.

Is Beauty Farm Medical and Health Industry now priced for perfection at 10.8x P/E, or does the earnings strength leave mispriced upside on the table? See how the…